Backlinks
| Referring page | DR | Ref. domains | Linked domains | Anchor and target URL |
|---|---|---|---|---|
|
crossject-franchit-une-nouvelle-etape-cle-dans-la-fabrica...
https://crossject.com/fr/actualite-2024/crossject-franchit-une-nouvelle-etape-cle-dans-la-fabrication-de-zepizure
crossject.com
|
12 | 6 | 14 |
Lire l’article
https://www.mypharma-editions.com/crossject-franchit-une-nouvelle-etape-cle-dans-la-fabrication-de-zepizure
NOFOLLOW
|
|
msd-france-lance-un-nouveau-site-internet-grand-public-su...
https://pharmageek.fr/msd-france-lance-un-nouveau-site-internet-grand-public-sur-la-gale
pharmageek.fr
|
9 | 3 | 153 |
www.mypharma-editions.com
http://www.mypharma-editions.com/msd-france-lance-un-nouveau-site-internet-grand-public-sur-la-gale
DOFOLLOW
|
|
brevet-europeen-pour-le-masitinib-2
https://strategiesante.com/brevet-europeen-pour-le-masitinib-2
strategiesante.com
|
17 | 1 | 74 |
MyPharma-Editions
https://www.mypharma-editions.com/ab-science-recoit-un-avis-dacceptation-pour-un-brevet-europeen-pour-le-masitinib-dans-le-cancer-de-la-prostate-metastatique-hormono-resistant
DOFOLLOW
|
|
what-medications-should-be-banned-in-2020-416
https://www.carenity.us/condition-information/magazine/advice/what-medications-should-be-banned-in-2020-416?0[mid]=268&;m[mid]=268
carenity.us
|
12 | 10 | 1,386 |
My Pharma Editions
https://www.mypharma-editions.com/prescrire-publie-son-bilan-2020-des-medicaments-a-ecarter
DOFOLLOW
|
|
112
https://initiativecitoyenne.be/page/112
initiativecitoyenne.be
|
19 | 51 | 490 |
Mypharma-editions.com
http://www.mypharma-editions.com/novartis-recoit-le-prix-galien-2013-de-la-recherche-pharmaceutique-pour-son-vaccin-bexsero
DOFOLLOW
|
|
70140000
https://www.alvinet.com/similaires/mercato-le-bayern-munich-multiplie-les-coups-de-fil-pour-marc-guehi-au-point-de-devancer-la-premier-league/70140000
alvinet.com
|
13 | 13 | 104 |
Le Leem concentre son action sur l'accès au progrès thérapeutique pour les patients et le dynamisme économique de la France
https://www.mypharma-editions.com/le-leem-concentre-son-action-sur-lacces-au-progres-therapeutique-pour-les-patients-et-le-dynamisme-economique-de-la-france
DOFOLLOW
|
|
covid19-everything-you-need-to-know-about-the-different-v...
https://www.carenity.us/condition-information/magazine/news/covid19-everything-you-need-to-know-about-the-different-vaccines-and-innovative-therapies-968
carenity.us
|
12 | 10 | 1,386 |
Xenothera annonce l’efficacité de XAV-19, son traitement anti-Covid, contre les variants du SARS-CoV-2, My pharma édition
https://www.mypharma-editions.com/xenothera-annonce-lefficacite-de-xav-19-son-traitement-anti-covid-contre-les-variants-du-sars-cov-2
DOFOLLOW
|
|
les-levees-de-fonds-q4-2015
https://www.eefficiency.fr/eefficiency/les-levees-de-fonds-q4-2015
eefficiency.fr
|
— | 0 | 69 |
Gamamabs Pharma
http://www.mypharma-editions.com/gamamabs-pharma-une-levee-de-15-millions-deuros-pour-mener-des-essais-dans-les-cancers-gynecologiques
DOFOLLOW
|
|
avc-des-videos-virales-pour-sensibiliser-aux-signaux-dale...
https://pharmageek.fr/avc-des-videos-virales-pour-sensibiliser-aux-signaux-dalerte-mypharma-editions-linfo-industrie-politique-de-sante
pharmageek.fr
|
9 | 3 | 153 |
www.mypharma-editions.com
http://www.mypharma-editions.com/avc-des-videos-virales-pour-sensibiliser-aux-signaux-dalerte
DOFOLLOW
|
|
on-parle-de-nous
https://experts-recherche-lymphome.org/on-parle-de-nous
experts-recherche-lymphome.org
|
63 | 9 | 97 |
l’article sur le LYSARC
https://www.mypharma-editions.com/le-lysa-senrichit-dune-commission-en-charge-de-la-leucemie-lymphoide-chronique-et-de-la-maladie-de-waldenstrom
DOFOLLOW
|
|
on-parle-de-nous
https://experts-recherche-lymphome.org/on-parle-de-nous
experts-recherche-lymphome.org
|
63 | 9 | 97 |
l’article sur le LYSARC
https://www.mypharma-editions.com/lysarc-et-roche-succes-prometteur-dun-anticorps-bi-specifique-montre-dans-une-etude-francaise
DOFOLLOW
|
|
Ermium_raised_6.3m
https://www.erganeo.com/index.php/en/Ermium_raised_6.3m
erganeo.com
|
13 | 9 | 79 |
Article from My Pharma Editions
https://www.mypharma-editions.com/maladies-auto-immunes-domain-therapeutics-investit-dans-ermium-therapeutics
DOFOLLOW
|
|
les-droits-et-obligations-lies-a-une-mutuelle-pour-person...
https://www.assurancemutuelle.re/mutuelle-la-reunion-pour-personne-agee-et-senior/les-droits-et-obligations-lies-a-une-mutuelle-pour-personne-agee-et-senior-a-la-reunion
assurancemutuelle.re
|
9 | 3 | 618 |
Tarifs et garanties
https://www.mypharma-editions.com/comment-choisir-la-meilleure-mutuelle-senior
DOFOLLOW
|
|
70110525
https://www.alvinet.com/similaires/coupe-de-france-pour-s-adapter-a-la-meteo-le-petit-poucet-montreuil-prepare-son-duel-contre-amiens-au-five/70110525
alvinet.com
|
13 | 13 | 104 |
Le Leem concentre son action sur l'accès au progrès thérapeutique pour les patients et le dynamisme économique de la France
https://www.mypharma-editions.com/le-leem-concentre-son-action-sur-lacces-au-progres-therapeutique-pour-les-patients-et-le-dynamisme-economique-de-la-france
DOFOLLOW
|
|
grippe h5n1 (aviaire)
https://initiativecitoyenne.be/tag/grippe%20h5n1%20%28aviaire%29
initiativecitoyenne.be
|
19 | 51 | 490 |
Mypharma-editions
http://www.mypharma-editions.com/grippe-aviaire-h5n1-lancement-dun-essai-clinique-de-phase-i-du-produit-de-fabentech
DOFOLLOW
|
|
fr-article-13-decembre-2021-mypharma-editions.com-geneuro...
https://apresj20revuedepresse.com/2021/12/fr-article-13-decembre-2021-mypharma-editions.com-geneuro-obtient-6-4-millions-d-euros-du-gouvernement-suisse-pour-le-developpement
apresj20revuedepresse.com
|
— | 0 | 222 |
GeNeuro obtient 6,4 millions d'euros du gouvernement suisse pour le développement du temelimab contre le COVID long
https://www.mypharma-editions.com/geneuro-obtient-64-millions-deuros-du-gouvernement-suisse-pour-le-developpement-du-temelimab-contre-le-covid-long
DOFOLLOW
|
|
forumvietnam.fr
|
38 | 3 | 1 |
printer_famfamfam.gif
NOFOLLOW
|
|
what-medications-should-be-banned-in-2020-416
https://www.carenity.us/condition-information/magazine/advice/what-medications-should-be-banned-in-2020-416?safesearch=moderate&setlang=es-ES
carenity.us
|
12 | 10 | 1,386 |
My Pharma Editions
https://www.mypharma-editions.com/prescrire-publie-son-bilan-2020-des-medicaments-a-ecarter
DOFOLLOW
|
|
paracetamol-1000mg-gelules-sanofi-aventis-et-le-quotidien...
https://jesuismalade.org/2011/12/01/paracetamol-1000mg-gelules-sanofi-aventis-et-le-quotidien-du-medecin
jesuismalade.org
|
54 | 7 | 154 |
http://www.mypharma-editions.com/pfizer-cede-capsugel-a-kkr-pour-2375-milliards-de-dollars
http://www.mypharma-editions.com/pfizer-cede-capsugel-a-kkr-pour-2375-milliards-de-dollars
DOFOLLOW
|
|
etre-paye-pour-se-faire-depister
https://cancer-rose.fr/2021/02/13/etre-paye-pour-se-faire-depister
cancer-rose.fr
|
15 | 15 | 298 |
(LEEM)
https://www.mypharma-editions.com/leem-eric-baseilhac-nomme-directeur-des-affaires-economiques
DOFOLLOW
|
|
demain-des-virus-pour-nous-soigner
https://popsciences.universite-lyon.fr/ressources/demain-des-virus-pour-nous-soigner
popsciences.universite-lyon.fr
|
65 | 42 | 1,347 |
Transgene : feu vert pour un essai clinique de TG6002 au Royaume-Uni dans le cancer colorectal avec métastases hépatiques
https://www.mypharma-editions.com/transgene-feu-vert-pour-un-essai-clinique-de-tg6002-au-royaume-uni-dans-le-cancer-colorectal-avec-metastases-hepatiques
DOFOLLOW
|
|
quels-medicaments-fautil-bannir-en-2020-418
https://www.carenity.de/informationen-krankheit/magazin/ratschlage/quels-medicaments-fautil-bannir-en-2020-418?0=organization_guest_main-feed-card_feed-article-content 18.172.170.10 8/4/2023
carenity.de
|
12 | 8 | 223 |
My Pharma Editions
https://www.mypharma-editions.com/prescrire-publie-son-bilan-2020-des-medicaments-a-ecarter
DOFOLLOW
|
|
des-tests-de-grossesse-bientot-disponibles-en-dehors-des-...
https://pharmageek.fr/des-tests-de-grossesse-bientot-disponibles-en-dehors-des-pharmacies
pharmageek.fr
|
9 | 3 | 153 |
www.mypharma-editions.com
http://www.mypharma-editions.com/des-tests-de-grossesse-bientot-disponibles-en-dehors-des-pharmacies
DOFOLLOW
|
|
innobio-2-la-france-soutient-son-industrie-de-sante
https://www.portail-ie.fr/univers/business-development-innovation-et-start-up/2018/innobio-2-la-france-soutient-son-industrie-de-sante
portail-ie.fr
|
68 | 74 | 1,027 |
(no anchor)
https://www.mypharma-editions.com/sciences-de-la-vie-lancement-du-fonds-dinvestissement-innobio-2
DOFOLLOW
|
|
vaccins-contre-le-cancer-prets-a-devenir-les-nouveaux-cob...
https://madame-raleuse.com/vaccins-contre-le-cancer-prets-a-devenir-les-nouveaux-cobayes-de-brenus-pharma
madame-raleuse.com
|
6 | 1 | 158 |
(source : My pharma)
https://www.mypharma-editions.com/cancer-brenus-pharma-leve-22-millions-deuros-pour-accelerer-le-passage-en-clinique-de-ses-vaccins-de-precision
DOFOLLOW
|
|
syndrome-de-down.html
https://lemedecin.fr/medical/pathologies/syndrome-de-down.html
lemedecin.fr
|
68 | 41 | 3 |
Lien
https://www.mypharma-editions.com/aelis-farma-resultats-positifs-de-son-etude-clinique-de-phase-1-2-avec-aef0217-chez-de-jeunes-adultes-avec-une-trisomie-21
NOFOLLOW
|
|
covid19-everything-you-need-to-know-about-the-virus-and-t...
https://www.carenity.us/condition-information/magazine/news/covid19-everything-you-need-to-know-about-the-virus-and-the-different-variants-982
carenity.us
|
12 | 10 | 1,386 |
Xenothera annonce l’efficacité de XAV-19, son traitement anti-Covid, contre les variants du SARS-CoV-2, My pharma édition
https://www.mypharma-editions.com/xenothera-annonce-lefficacite-de-xav-19-son-traitement-anti-covid-contre-les-variants-du-sars-cov-2
DOFOLLOW
|
|
cell-easy-3
https://www.irdi.fr/cell-easy-3
irdi.fr
|
14 | 14 | 79 |
Accéder à l'article
https://www.mypharma-editions.com/cell-easy-entree-au-capital-de-merieux-equity-partners-en-tant-quactionnaire-de-reference
DOFOLLOW
|
|
what-medications-should-be-banned-in-2020-416
https://www.carenity.us/condition-information/magazine/advice/what-medications-should-be-banned-in-2020-416?0=organization_guest_m
carenity.us
|
12 | 10 | 1,386 |
My Pharma Editions
https://www.mypharma-editions.com/prescrire-publie-son-bilan-2020-des-medicaments-a-ecarter
DOFOLLOW
|
|
fealinx-est-partenaire-du-consortium-pspc-pacific
http://www.fealinx-biomedical.com/fr/2022/11/16/fealinx-est-partenaire-du-consortium-pspc-pacific
fealinx-biomedical.com
|
42 | 1 | 18 |
www.mypharma-editions.com
https://www.mypharma-editions.com/le-consortium-pacific-entend-redefinir-linsuffisance-cardiaque-a-fraction-dejection-preservee-icfep
DOFOLLOW
|
|
fealinx-est-partenaire-du-consortium-pspc-pacific
http://www.fealinx-biomedical.com/fr/2022/11/16/fealinx-est-partenaire-du-consortium-pspc-pacific
fealinx-biomedical.com
|
42 | 1 | 18 |
www.mypharma-editions.com
https://www.mypharma-editions.com/le-consortium-pacific-entend-redefinir-linsuffisance-cardiaque-a-fraction-dejection-preservee-icfep
DOFOLLOW
|
|
what-medications-should-be-banned-in-2020-416
https://www.carenity.us/condition-information/magazine/advice/what-medications-should-be-banned-in-2020-416?cc=IT&darkschemeovr=1&safesearch=moderate&setlang=it&ssp=1
carenity.us
|
12 | 10 | 1,386 |
My Pharma Editions
https://www.mypharma-editions.com/prescrire-publie-son-bilan-2020-des-medicaments-a-ecarter
DOFOLLOW
|
|
7
https://initiativecitoyenne.be/tag/vaccin%20a%20tout%20prix%20%28ideologie%20du%29/7
initiativecitoyenne.be
|
19 | 51 | 490 |
mypharma-editions.com
http://www.mypharma-editions.com/sanofi-pasteur-lance-une-etude-de-phase-iii-dun-vaccin-contre-le-clostridium-difficile
DOFOLLOW
|
|
Kadrige
https://plus.wikimonde.com/wiki/Kadrige
plus.wikimonde.com
|
72 | 63 | 16 |
http://www.mypharma-editions.com/quintiles-et-kadrige-lancent-leur-operation-de-solutions-electroniques-ouvertes-aux-etats-unis
http://www.mypharma-editions.com/quintiles-et-kadrige-lancent-leur-operation-de-solutions-electroniques-ouvertes-aux-etats-unis
NOFOLLOW
|
|
medicaments-le-gouvernement-encadre-la-vente-sur-internet...
https://pharmageek.fr/medicaments-le-gouvernement-encadre-la-vente-sur-internet-mypharma-editions-linfo-industrie-politique-de-sante
pharmageek.fr
|
9 | 3 | 153 |
www.mypharma-editions.com
http://www.mypharma-editions.com/medicaments-le-gouvernement-encadre-la-vente-sur-internet
DOFOLLOW
|
|
aelis-farma-resultats-positifs-de-son-etude-clinique-de-p...
https://lmc.today/aelis-farma-resultats-positifs-de-son-etude-clinique-de-phase-1-2-avec-aef0217-chez-de-jeunes-adultes-avec-une-trisomie-21
lmc.today
|
7 | 1 | 131 |
[Lire plus…]
https://www.mypharma-editions.com/aelis-farma-resultats-positifs-de-son-etude-clinique-de-phase-1-2-avec-aef0217-chez-de-jeunes-adultes-avec-une-trisomie-21
DOFOLLOW
|
|
candidats-medicaments-dans-les-cancers-gastro-intestinaux
https://strategiesante.com/candidats-medicaments-dans-les-cancers-gastro-intestinaux
strategiesante.com
|
17 | 1 | 74 |
Mypharma-editions
https://www.mypharma-editions.com/cancers-gastro-intestinaux-biper-therapeutics-leve-125-million-deuros-en-amorcage-pour-developper-des-petites-molecules-first-in-class
DOFOLLOW
|
|
carenity.us
|
12 | 10 | 1,386 |
Xenothera annonce l’efficacité de XAV-19, son traitement anti-Covid, contre les variants du SARS-CoV-2, My pharma édition
https://www.mypharma-editions.com/xenothera-annonce-lefficacite-de-xav-19-son-traitement-anti-covid-contre-les-variants-du-sars-cov-2
DOFOLLOW
|
|
french-tech-funding-wire-september-26-waat-nxtfood-goodve...
https://www.frenchtechjournal.com/french-tech-funding-wire-september-26-waat-nxtfood-goodvest-more
frenchtechjournal.com
|
55 | 18 | 707 |
MyPharma
https://www.mypharma-editions.com/steminov-leve-106-millions-deuros-pour-soutenir-son-developpement-industriel-et-clinique?ref=frenchtechjournal.com
DOFOLLOW
|
|
comparatif-des-mutuelles-pour-retraites
https://www.assurancemutuelle.re/quelle-mutuelle-rembourse-le-mieux-pour-les-retraites/comparatif-des-mutuelles-pour-retraites
assurancemutuelle.re
|
9 | 3 | 618 |
mutuelles disponibles sur le marché
https://www.mypharma-editions.com/comment-choisir-la-meilleure-mutuelle-senior
DOFOLLOW
|
▾
Frequently Asked Questions
How many backlinks does mypharma-editions.com have?
The backlinks page for mypharma-editions.com shows all individual inbound links discovered in our crawl of the web. Each backlink represents a hyperlink on another website that points to a page on mypharma-editions.com. Use the filters to narrow results by dofollow/nofollow status, domain rating, or anchor text.
What is a backlink?
A backlink is a hyperlink on one website that points to a page on a different website. Backlinks are one of the most important ranking factors in search engine algorithms because they act as votes of confidence from other sites. The more high-quality backlinks a domain has, the more authority search engines assign to it.
Are the backlinks to mypharma-editions.com dofollow or nofollow?
Backlinks to mypharma-editions.com include both dofollow and nofollow links. Dofollow links pass link equity (ranking power) to the target site, while nofollow links include a rel="nofollow" attribute that tells search engines not to pass authority. Both types contribute to a natural backlink profile, but dofollow links carry more SEO weight. You can filter by link type using the rel filter above the table.
How often is backlink data updated?
Backlink data is updated monthly when our web crawler completes a new cycle. Our pipeline processes billions of web pages to discover new backlinks, track lost links, and update domain authority scores. The freshness of data depends on when our crawler last visited the referring pages.